- Telehealth Visits
- Insurance plan information
Wade S. Smith, MD
Neurology • Vascular NeurologyDirector, UCSF Neurovascular Service- Telehealth Visits
- Insurance plan information
Wade S. Smith, MD
Neurology • Vascular NeurologyDirector, UCSF Neurovascular Service- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Wade Smith, director of the UCSF Neurovascular Service, specializes in stroke prevention, management of acute stroke, critical care medicine and medical management after stroke. He has expertise in transcranial Doppler techniques for cerebral blood-flow monitoring. As a neurointensivist – a specialist in both critical care and neurology – he directs UCSF's 16-bed neurological intensive care unit, dedicated to patients with neurological injuries. He evaluates many patients who have been referred for a second or third opinion, though he also evaluates patients who are seeing a neurologist for the first time.
Smith earned both his medical degree and a doctorate in neurophysiology from the University of Washington. He completed a residency as well as a fellowship in critical care medicine at UCSF.
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Critical Care Anesthesia, UCSF Graduate Medical Education
Residency
- Neurology, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, University of Washington
My expertise
Specialties
- Neurology
- Vascular Neurology
- Stroke
- Neurocritical Care
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22460%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22460%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.